ArticleFrontiers in pharmacology2025

Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation.

Ni Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.